337 related articles for article (PubMed ID: 33550445)
1. Molecular targeted treatment and drug delivery system for gastric cancer.
Jiang L; Gong X; Liao W; Lv N; Yan R
J Cancer Res Clin Oncol; 2021 Apr; 147(4):973-986. PubMed ID: 33550445
[TBL] [Abstract][Full Text] [Related]
2. Chitosan: A compound for drug delivery system in gastric cancer-a review.
Shafabakhsh R; Yousefi B; Asemi Z; Nikfar B; Mansournia MA; Hallajzadeh J
Carbohydr Polym; 2020 Aug; 242():116403. PubMed ID: 32564837
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy in advanced gastric carcinoma: the future is beginning.
Schinzari G; Cassano A; Orlandi A; Basso M; Barone C
Curr Med Chem; 2014; 21(8):1026-38. PubMed ID: 24304282
[TBL] [Abstract][Full Text] [Related]
4. Current advances in targeted therapies for metastatic gastric cancer: improving patient care.
Aguiar PN; Muniz TP; Miranda RR; Tadokoro H; Forones NM; Monteiro ID; Castelo-Branco P; Janjigian YY; De Mello RA
Future Oncol; 2016 Mar; 12(6):839-54. PubMed ID: 26838766
[TBL] [Abstract][Full Text] [Related]
5. Targeting HER 2 and angiogenesis in gastric cancer.
Jomrich G; Schoppmann SF
Expert Rev Anticancer Ther; 2016; 16(1):111-22. PubMed ID: 26567753
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapies in gastric cancer treatment: where we are and where we are going.
Tomasello G; Ghidini M; Liguigli W; Ratti M; Toppo L; Passalacqua R
Invest New Drugs; 2016 Jun; 34(3):378-93. PubMed ID: 26873643
[TBL] [Abstract][Full Text] [Related]
7. Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer.
Chen Z; Li Y; Tan B; Zhao Q; Fan L; Li F; Zhao X
Drugs Today (Barc); 2020 Jul; 56(7):469-482. PubMed ID: 32648857
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapies in the treatment of gastric cancer.
Ngeow J; Tan IB; Choo SP
Asia Pac J Clin Oncol; 2011 Sep; 7(3):224-35. PubMed ID: 21884434
[TBL] [Abstract][Full Text] [Related]
9. Changing strategies for target therapy in gastric cancer.
Lee SY; Oh SC
World J Gastroenterol; 2016 Jan; 22(3):1179-89. PubMed ID: 26811656
[TBL] [Abstract][Full Text] [Related]
10. Metastatic gastric cancer treatment: a little slow but worthy progress.
Kanat O; O'Neil BH
Med Oncol; 2013 Mar; 30(1):464. PubMed ID: 23335104
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles guided drug delivery and imaging in gastric cancer.
Nagaraju GP; Srivani G; Dariya B; Chalikonda G; Farran B; Behera SK; Alam A; Kamal MA
Semin Cancer Biol; 2021 Feb; 69():69-76. PubMed ID: 31954835
[TBL] [Abstract][Full Text] [Related]
12. Evolving standards of care in advanced gastric cancer.
Kurtz JE; Dufour P
Future Oncol; 2011 Dec; 7(12):1441-50. PubMed ID: 22112319
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of targeted agents in the management of patients with advanced gastric cancer.
Pentheroudakis G; Stoyianni A
Curr Med Chem; 2011; 18(11):1629-39. PubMed ID: 21428884
[TBL] [Abstract][Full Text] [Related]
14. Gastric cancer in the era of molecularly targeted agents: current drug development strategies.
Arkenau HT
J Cancer Res Clin Oncol; 2009 Jul; 135(7):855-66. PubMed ID: 19363621
[TBL] [Abstract][Full Text] [Related]
15. Gastric Cancer: Nanoparticles as Tools to Improve Treatment Efficacy.
Guerrero AR; Oyarzun-Ampuero F; Hassan N; Corvalán AH; Quest AF; Kogan MJ
Curr Pharm Des; 2016; 22(39):5988-5997. PubMed ID: 27412042
[TBL] [Abstract][Full Text] [Related]
16. Management of advanced gastric cancer.
Price TJ; Shapiro JD; Segelov E; Karapetis CS; Pavlakis N; Van Cutsem E; Shah MA; Kang YK; Tebbutt NC
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):199-208; quiz 209. PubMed ID: 22375525
[TBL] [Abstract][Full Text] [Related]
17. Second-line Treatment of Advanced Gastric Cancer: Current Options and Future Perspectives.
Chrom P; Stec R; Szczylik C
Anticancer Res; 2015 Sep; 35(9):4575-83. PubMed ID: 26254345
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and novel agents in esophago-gastric cancer: are we making progress?
Dahle-Smith A; Petty RD
Expert Rev Anticancer Ther; 2015; 15(9):1103-19. PubMed ID: 26313419
[TBL] [Abstract][Full Text] [Related]
19. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy for gastric adenocarcinoma.
Almhanna K
Adv Pharmacol; 2012; 65():437-70. PubMed ID: 22959034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]